PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
17-Dec-2025 HUTCHMED Initiates Global Clinical Development of ATTC Candidate HMPL-A251 in Patients with Solid Tumors HUTCHMED
17-Dec-2025 Senzime’s Next-generation TetraGraph system receives regulatory approval in Japan Senzime
17-Dec-2025 numares Health enters ASEAN region with regulatory approval in Malaysia and first contract win for AXINON ® LDLp Test System numares Health
17-Dec-2025 Cartherics to Participate in Prominent Biotech Investor Conferences During JPM Healthcare Week Cartherics
16-Dec-2025 Leucid Bio and Syenex Announce Strategic Collaboration for In Vivo CAR-T Cell Engineering Leucid Bio
16-Dec-2025 Linus Health Adds Deep Clinical and Public Health Experience with Appointment of Julie Wood, MD, MPH, FAAFP, as Senior Medical Director, Clinician Engagement Linus Health
16-Dec-2025 Saphnelo approved in the EU for subcutaneous self-administration as a new pre-filled pen for systemic lupus erythematosus AstraZeneca
16-Dec-2025 Jesper Hagberg appointed as Chief Operations & Digital Officer for BICO Group AB BICO Group AB
16-Dec-2025 Akiram Therapeutics: Cohort 2a completed and cohort 2b cleared to start in Phase I trial of AKIR001 Akiram Therapeutics
16-Dec-2025 EIFO and FSG back Fida Biosystems with €5M Series A investment to further accelerate the growth of the company. EIFO
15-Dec-2025 Novadip recruits first pediatric patients in pivotal phase 3 trial of tissue regenerative treatment NVD003 in congenital pseudoarthrosis of the tibia Andrew Lloyd Associates
15-Dec-2025 Everest Medicines Announces Commercialization Service Agreement and License Agreement with Hasten Everest Medicines Limited
12-Dec-2025 Novadip Biosciences Andrew Lloyd Associates
11-Dec-2025 ProteoNic 2G UNic® Technology Licensed by Ginkgo Bioworks for BARDA-Supported Consortium Advancing Monoclonal Antibody Manufacturing for Anti-Filovirus Therapies ProteoNic
11-Dec-2025 Boston Scientific and BPH treatment with Rezūm™ Water Vapour Therapy Boston Scientific
11-Dec-2025 Gaelic Labs’ acquisition of Athlone boosts Gaelic’s leadership in the Beta Lactam industry Gaelic Labs
11-Dec-2025 Mabylon AG Initiates Phase I Clinical Trial of Lead Compound MY006 for the Treatment of Peanut Allergy Mabylon AG
10-Dec-2025 Senzime unveils the next set of innovations in neuromuscular monitoring with the launch of EMGINE Sirius Senzime
10-Dec-2025 First Patient Dosed in Part 2 of Modus Therapeutics’ Phase IIa Study in Chronic Kidney Disease with Anemia Modus Therapeutics
10-Dec-2025 PLL Therapeutics opens subsidiary in New Zealand to accelerate ALS (Amyotrophic Lateral Sclerosis) treatment and early diagnostics breakthroughs PLL Therapeutics